These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 6208211

  • 21. Somatomedin binding proteins in GH-deficient children with normal plasma somatomedin levels.
    Cohen DA, Blethen SL.
    J Clin Endocrinol Metab; 1983 Mar; 56(3):461-6. PubMed ID: 6185524
    [Abstract] [Full Text] [Related]

  • 22. Double blind trial comparing the effects of two doses of growth hormone in prepubertal patients with chronic renal insufficiency.
    Hokken-Koelega AC, Stijnen T, De Jong MC, Donckerwolcke RA, De Muinck Keizer-Schrama SM, Blum WF, Drop SL.
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1185-90. PubMed ID: 7525628
    [Abstract] [Full Text] [Related]

  • 23. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
    Juul A, Scheike T, Nielsen CT, Krabbe S, Müller J, Skakkebaek NE.
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
    [Abstract] [Full Text] [Related]

  • 24. The insulin-like growth factor (IGF)-binding proteins and IGF bioactivity in Laron-type dwarfism.
    Cotterill AM, Holly JM, Taylor AM, Davies SC, Coulson VJ, Preece MA, Wass JA, Savage MO.
    J Clin Endocrinol Metab; 1992 Jan; 74(1):56-63. PubMed ID: 1370165
    [Abstract] [Full Text] [Related]

  • 25. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
    Thorén M, Hilding A, Baxter RC, Degerblad M, Wivall-Helleryd IL, Hall K.
    J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
    [Abstract] [Full Text] [Related]

  • 26. Kinetics of the somatomedin C/insulin-like growth factor I: response to exogenous growth hormone (GH) in GH-deficient children.
    Blethen SL, Daughaday WH, Weldon VV.
    J Clin Endocrinol Metab; 1982 May; 54(5):986-90. PubMed ID: 7037825
    [Abstract] [Full Text] [Related]

  • 27. Normative data for insulin-like growth factors (IGFs), IGF-binding proteins, and growth hormone-binding protein in a healthy Spanish pediatric population: age- and sex-related changes.
    Argente J, Barrios V, Pozo J, Muñoz MT, Hervás F, Stene M, Hernández M.
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1522-8. PubMed ID: 7505288
    [Abstract] [Full Text] [Related]

  • 28. Somatomedins in adolescence: a cross-sectional study of the effect of puberty on plasma insulin-like growth factor I and II levels.
    Luna AM, Wilson DM, Wibbelsman CJ, Brown RC, Nagashima RJ, Hintz RL, Rosenfeld RG.
    J Clin Endocrinol Metab; 1983 Aug; 57(2):268-71. PubMed ID: 6345568
    [Abstract] [Full Text] [Related]

  • 29. Management of the short stature due to pubertal delay in boys.
    Adan L, Souberbielle JC, Brauner R.
    J Clin Endocrinol Metab; 1994 Feb; 78(2):478-82. PubMed ID: 7508951
    [Abstract] [Full Text] [Related]

  • 30. Molecular forms of serum insulin-like growth factor (IGF)-binding proteins in man: relationships with growth hormone and IGFs and physiological significance.
    Hardouin S, Gourmelen M, Noguiez P, Seurin D, Roghani M, Le Bouc Y, Povoa G, Merimee TJ, Hossenlopp P, Binoux M.
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1291-301. PubMed ID: 2555386
    [Abstract] [Full Text] [Related]

  • 31. Diurnal rhythm of growth hormone-independent binding protein for insulin-like growth factors in human plasma.
    Baxter RC, Cowell CT.
    J Clin Endocrinol Metab; 1987 Sep; 65(3):432-40. PubMed ID: 2442187
    [Abstract] [Full Text] [Related]

  • 32. Insulin-like growth factor I, its binding proteins 1 and 3, and growth hormone-binding protein in children and adolescents with insulin-dependent diabetes mellitus: clinical implications.
    Muñoz MT, Barrios V, Pozo J, Argente J.
    Pediatr Res; 1996 Jun; 39(6):992-8. PubMed ID: 8725260
    [Abstract] [Full Text] [Related]

  • 33. Twenty-four-hour plasma growth hormone (GH) profiles, urinary GH excretion, and plasma insulin-like growth factor-I and -II levels in prepubertal children with chronic renal insufficiency and severe growth retardation.
    Hokken-Koelega AC, Hackeng WH, Stijnen T, Wit JM, de Muinck Keizer-Schrama SM, Drop SL.
    J Clin Endocrinol Metab; 1990 Sep; 71(3):688-95. PubMed ID: 2394775
    [Abstract] [Full Text] [Related]

  • 34. Measurement of somatomedin-related peptides in fetal, neonatal, and maternal rat serum by insulin-like growth factor (IGF) I radioimmunoassay, IGF-II radioreceptor assay (RRA), and multiplication-stimulating activity RRA after acid-ethanol extraction.
    Daughaday WH, Parker KA, Borowsky S, Trivedi B, Kapadia M.
    Endocrinology; 1982 Feb; 110(2):575-81. PubMed ID: 7035142
    [Abstract] [Full Text] [Related]

  • 35. Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients.
    Fielder PJ, Guevara-Aguirre J, Rosenbloom AL, Carlsson L, Hintz RL, Rosenfeld RG.
    J Clin Endocrinol Metab; 1992 Apr; 74(4):743-50. PubMed ID: 1372321
    [Abstract] [Full Text] [Related]

  • 36. Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency.
    Juul A, Holm K, Kastrup KW, Pedersen SA, Michaelsen KF, Scheike T, Rasmussen S, Müller J, Skakkebaek NE.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2497-502. PubMed ID: 9253324
    [Abstract] [Full Text] [Related]

  • 37. Growth hormone treatment in short children: relationship between growth and serum insulin-like growth factor I and II levels.
    Albertsson-Wikland K, Hall K.
    J Clin Endocrinol Metab; 1987 Oct; 65(4):671-8. PubMed ID: 3654912
    [Abstract] [Full Text] [Related]

  • 38. Radioimmunoassay of a 26,000-dalton plasma insulin-like growth factor-binding protein: control by nutritional variables.
    Busby WH, Snyder DK, Clemmons DR.
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1225-30. PubMed ID: 2461386
    [Abstract] [Full Text] [Related]

  • 39. Effect of insulin on the insulin-like growth factor system in children with new-onset insulin-dependent diabetes mellitus.
    Bereket A, Lang CH, Blethen SL, Gelato MC, Fan J, Frost RA, Wilson TA.
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1312-7. PubMed ID: 7536205
    [Abstract] [Full Text] [Related]

  • 40. Measurement of insulin-like growth factor II by a specific radioreceptor assay in serum of normal individuals, patients with abnormal growth hormone secretion, and patients with tumor-associated hypoglycemia.
    Daughaday WH, Trivedi B, Kapadia M.
    J Clin Endocrinol Metab; 1981 Aug; 53(2):289-94. PubMed ID: 7019228
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.